HIMS Hims Hers Health Inc
Company Analysis
Latest News
Hims & Hers falls, as BofA flags weight-loss churn risk
Hims & Hers Health (HIMS) shares fell for a third consecutive day following a Bank of America Securities warning. Analysts identified significant risks to the...
🔴 Hims Hers Health is trading 4% down today on Amazon competition fears and broader risk-off sentiment
Hims Hers Health is trading at $34.03 (-4.01%) as macroeconomic pressures and competitive threats weigh on the stock. • Broader risk sentiment is being driven...
🔴 HIMS is trading 4.2% down today as profit-taking extends its post-rally pullback
HIMS is trading 4.2% down at $34.66, extending a sharp two-day pullback following last week’s powerful rally. • The decline follows a significant run-up...
🔴 HIMS is trading 4.3% down today as it extends a pullback from recent highs amid weaker index futures
HIMS is trading 4.3% down at $34.60 in pre-market, extending Tuesday’s decline as the stock pulls back from a sharp multi-day rally. • The move appears to be...
🔴 HIMS is trading 4.2% down today as it pulls back from its July 6 rally
HIMS is trading at $36.66 (4.2% down) as the stock pulls back from its July 6 rally amid broader market weakness. • The decline follows a 4.02% move higher in...
Hims & Hers Enters $400M Receivables Purchase Agreement with JPMorgan Chase
Hims & Hers Health, Inc. announced that its subsidiaries have entered into a Master Receivables Purchase Agreement (RPA) with JPMorgan Chase Bank, N.A. The...
🟢 HIMS makes sharp 10.1% jump
HIMS is trading at $38.17, up 10.1% versus the comparison close of $34.67 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 HIMS Rises 5.4% After Canaccord and Bank of America Boost Price Targets
HIMS is trading 5.4% up today at $36.55 after Canaccord raised its price target to $40 from $32, maintaining a Buy rating. Bank of America also increased its...
🟢 HIMS is trading 5.5% up today as GLP-1 coverage cuts boost outlook
HIMS is trading 5.5% up today at $34.51 as upbeat sentiment grows around its cash-pay GLP-1 weight-loss business following reports of insurance coverage...
Hims & Hers gains as employers drop GLP-1 coverage, boosting cash sales
Hims & Hers Health expects a significant boost in its weight-loss business as employers drop coverage for GLP-1 drugs like Wegovy and Zepbound. Soaring costs...
🔴 HIMS extends move to 5.9% down
HIMS is trading at $30.77, down 5.9% versus the comparison close of $32.70 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 HIMS is trading 5% down today amid GLP-1 supply uncertainty and valuation concerns
HIMS is trading about 5% down today at $31.07 as the stock gives back gains from a recent rebound amid persistent GLP-1 supply uncertainty and valuation...
🔴 Hims Hers Health Inc extends move to 5.0% down
HIMS is trading at $33.68, down 5.0% versus the comparison close of $35.47 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Hims Hers Health Inc is trading 4.7% down today amid insider share sale and GLP-1 market volatility
Hims Hers Health Inc is trading 4.7% down today at $33.81. Chief Medical Officer Patrick Carroll filed to sell up to 23,726 shares worth about $830,000**...
🟢 Hims Hers Health Inc makes sharp 10.5% jump
HIMS is trading at $35.25, up 10.5% versus the comparison close of $31.89 during regular trading. This is a price-movement alert; no separate company-specific...
Barclays Bets Big on Hims & Hers' Weight-Loss Comeback — But Can the Margins Keep Up With the Momentum?
Shares surged as Barclays handed Hims & Hers Health its most aggressive Wall Street endorsement in months, lifting its price target 34% — from $29 to $39 — and...
🟢 Hims Hers Health Inc is trading 6.9% up today after Barclays raised its price target on strong GLP-1 growth momentum
Hims Hers Health Inc is trading 6.9% up at $34.09 following a bullish note from Barclays highlighting significant reacceleration in the company’s weight loss...
Hims & Hers Eyes 34% Upside, Driven by GLP-1 Growth
Barclays raised its price target for Hims & Hers Health (NYSE: HIMS) to $39 from $29. This adjustment represents a potential upside of more than 34%. The bank...
🟢 Hims Hers Health Inc extends move to 5.1% up
HIMS is trading at $33.08, up 5.1% versus the comparison close of $31.47 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Hims Hers Health Inc is trading 4.1% up today as weight-loss growth expectations fuel multi-day rally
Hims Hers Health Inc is trading 4.1% up now at $32.75 as investors extend a sharp multi-day rally following bullish growth expectations in new weight-loss...